OpenAI and the FDA are reportedly discussing AI for drug evaluations

techcrunch.com/2025/05/07/openai-and-the-fda-are-reportedly-discussing-ai-for-drug-evaluations

OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday.
According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the…

This story appeared on techcrunch.com, 2025-05-07 21:09:41.
The Entire Business World on a Single Page. Free to Use →